Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Lipoid Glomerulosclerosis”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Large-scale testing (Phase 3)Study completedNCT00065611
What this trial is testing

Steroid Treatment for Kidney Disease

Who this might be right for
NephrosisFocal Lipoid Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableNot Yet RecruitingNCT06443034
What this trial is testing

Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease
Assistance Publique - Hôpitaux de Paris 124
Not applicableLooking for participantsNCT04924712
What this trial is testing

INS, B Cells and Microbiota

Who this might be right for
MicrobiotaB-lymphocytesGlomerulosclerosis+1 more
Nantes University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04950114
What this trial is testing

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Who this might be right for
Kidney DiseasesGlomerulosclerosisFocal Segmental Nephrosis+4 more
Goldfinch Bio, Inc. 31
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Not applicableEnded earlyNCT04235621
What this trial is testing

Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies
Goldfinch Bio, Inc. 20
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Not applicableLooking for participantsNCT05583942
What this trial is testing

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 10
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Post-approval studies (Phase 4)Study completedNCT01129284
What this trial is testing

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Who this might be right for
Treatment Resistant Nephrotic Syndrome
Columbia University 15
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Large-scale testing (Phase 3)UnknownNCT02896270
What this trial is testing

Valproic Acid for Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Universitair Ziekenhuis Brussel 15
Testing effectiveness (Phase 2)Study completedNCT04009668
What this trial is testing

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Who this might be right for
FSGSMCDFocal Segmental Glomerulosclerosis+1 more
University of Michigan 7
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Load More Results